Trial intelligence / Profile preview

Carbetocin vs Misoprostol for PPH Prevention in High Risk C-Section

NCT02277067Phase 4Unknown

Sponsor
Beni Suef University
Start
Oct 2014
Primary completion
Aug 2021
Modality
Peptides
Countries
1
01

Overview

Phase 4, randomised, open-label trial of carbetocin in postpartum hemorrhage (PPH) (2 arms), sponsored by Beni Suef University. Primary endpoint: Uterine tone and size at 1 hour. Status: unknown.

02

Drugs

carbetocin
03

Conditions

postpartum hemorrhage (PPH)

Beyond the preview

Go deeper on NCT02277067.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT02277067.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call